Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$13.03 USD
-1.22 (-8.56%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $13.04 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -1.07 |
EPS Last Quarter | -1.35 |
Last EPS Surprise | -25.00% |
ABR | 1.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.39 |
Next Year | -4.29 |
EPS (TTM) | -5.32 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.08M | 0.09M | 0.33M | 14.02M |
# of Estimates | 2 | 2 | 2 | 3 |
High Estimate | 0.08M | 0.10M | 0.35M | 40.70M |
Low Estimate | 0.08M | 0.08M | 0.30M | 0.35M |
Year ago Sales | 0.10M | 0.07M | 0.31M | 0.33M |
Year over Year Growth Est. | -20.00% | 28.57% | 3.50% | 4,212.62% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.07 | -1.05 | -4.39 | -4.29 |
# of Estimates | 7 | 7 | 9 | 8 |
Most Recent Consensus | -1.36 | -1.32 | -5.46 | -6.69 |
High Estimate | -0.88 | -0.84 | -3.44 | -3.23 |
Low Estimate | -1.36 | -1.32 | -5.72 | -6.69 |
Year ago EPS | -1.61 | -1.27 | -5.31 | -4.39 |
Year over Year Growth Est. | 33.54% | 17.32% | 17.33% | 2.28% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.07 | -1.05 | -4.39 | -4.29 |
7 Days Ago | -1.07 | -1.05 | -4.39 | -4.29 |
30 Days Ago | -1.07 | -1.05 | -4.39 | -4.29 |
60 Days Ago | -1.00 | -1.03 | -4.27 | -4.20 |
90 Days Ago | -1.02 | -1.06 | -4.29 | -4.23 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.07 | -1.05 | -4.39 | -4.29 |
Zacks Consensus Estimate | -1.07 | -1.05 | -4.39 | -4.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.35 | -1.09 | -1.27 | -1.61 | NA |
Estimate | -1.08 | -1.22 | -1.26 | -1.00 | NA |
Difference | -0.27 | 0.13 | -0.01 | -0.61 | -0.19 |
Surprise | -25.00% | 10.66% | -0.79% | -61.00% | -19.03% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more